"Seinäjoen keskussairaala tarjoaa erikoissairaanhoidon päivystyspalveluita ympäri vuorokauden ja lisäksi erikoislääkäreiden toteuttamia kiireettömän hoidon palveluja kaikilla keskeisillä erikoisaloilla."

During the past decade, Seinäjoki Central Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seinäjoki Central Hospital" #1 sponsor was "University of Oulu" with 6 trials, followed by "Turku University Hospital" with 3 trials sponsored, "Helsinki University Central Hospital" with 2 trials sponsored, "University of Helsinki" with 2 trials sponsored and "Central Finland Hospital District" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seinäjoki Central Hospital" #1 collaborator was "Seinajoki Central Hospital" with 6 trials as a collaborator, "Oulu University Hospital" with 4 trials as a collaborator, "Kuopio University Hospital" with 3 trials as a collaborator, "Tampere University Hospital" with 3 trials as a collaborator and "Finnbladder" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Seinäjoki Central Hospital" are "Bladder Cancer" (2 trials), "Rectal Adenocarcinoma" (2 trials), "Abdominoperineal Resection" (1 trials), "Acute Appendicitis" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Seinäjoki Central Hospital" in a lesser frequency.

Most popular intervention types in "Seinäjoki Central Hospital" are "Procedure" (7 trials), "Drug" (6 trials), "Device" (5 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Parietene Macro" (2 trials), "Placebo" (2 trials), "Airvo (TM, Fisher & Paykel Healthcare) - High flow oxygen therapy" (1 trials), "Appendicectomy" (1 trials) and "BCG instillation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seinäjoki Central Hospital" are 20 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Seinäjoki Central Hospital". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 3 completed trials in Seinäjoki Central Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Seinäjoki Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".